Atlas Trials

Trastuzumab Based Therapy in HER2 Positive AGC

Clinical trial NCT03024450 · COMPLETED

Trial details

NCT number
NCT03024450
Sponsor
Shanghai Zhongshan Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Gastric Adenocarcinoma
Start date
2012-01-01
Primary completion
2016-05-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.